Literature DB >> 4542596

Evidence for a preferential effect of cyclophosphamide on B-cells.

J L Turk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4542596      PMCID： PMC1645136     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  6 in total

1.  Central and peripheral effects of anti-lymphocyte sera.

Authors:  J L Turk; D A Willoughby
Journal:  Lancet       Date:  1967-02-04       Impact factor: 79.321

2.  Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; D Parker; L W Poulter
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

3.  Selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; L W Poulter
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

4.  Further studies on B-lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity.

Authors:  J L Turk; D Parker
Journal:  Immunology       Date:  1973-04       Impact factor: 7.397

5.  Thymus-dependent areas in the lymphoid organs of neonatally thymectomized mice.

Authors:  D V Parrott; M A De Sousa; J East
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

6.  Studies on the sensitization of animals with simple chemical compounds. XII. The influence of excision of allergenic depots on onset of delayed hypersensitivity and tolerance.

Authors:  E Macher; M W Chase
Journal:  J Exp Med       Date:  1969-01-01       Impact factor: 14.307
  6 in total
  8 in total

1.  Protective effects of indomethacin and cyclophosphamide but not of infliximab on liver metabolic changes caused by adjuvant-induced arthritis.

Authors:  Maria Angélica Raffaini Covas Pereira da Silva; Ciomar Aparecida Bersani-Amado; Emy Luiza Ishii-Iwamoto; Lívia Bracht; Silvana Martins Caparroz-Assef
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

Review 2.  The role of antibody in T-cell responses.

Authors:  J H Playfair
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

3.  Effects of "Bordetella pertussis" on hemic colony-forming cells and immune response.

Authors:  E M Uyeki; A ElAshkar; T L Pazdernik
Journal:  Agents Actions       Date:  1974-10

4.  Suppression of rat adjuvant disease by cyclophosphamide pretreatment: evidence for an antibody mediated component in the pathogenesis of the disease.

Authors:  A R Mackenzie; C R Pick; P R Sibley; B P White
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

5.  The effect of cyclophosphamide on MSV-H oncogenesis.

Authors:  M Branca; L Nicoletti
Journal:  Br J Cancer       Date:  1977-10       Impact factor: 7.640

6.  Mouse model for abortive rabies infection of the central nervous system.

Authors:  J S Smith
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

7.  Brain lysosomal glycosidase activity in immunosuppressed mice infected with avirulent Semliki forest virus.

Authors:  A J Suckling; S Jagelman; H E Webb
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

8.  Recovery of immune responsiveness to rabies vaccine after treatment of mice with cyclophosphamide.

Authors:  G S Turner
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.